The CK2α/CK2β Interface of Human Protein Kinase CK2 Harbors a Binding Pocket for Small Molecules

Chemistry and Biology

Volumn 15, Issue 2, 2008, Pages 111-117

  Raaf, Jennifer ^a   Brunstein, Elena ^a   Issinger, Olaf Georg ^b   Niefind, Karsten ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

CHEMBIO; PROTEINS; SIGNALING

Indexed keywords

5,6 DICHLOROBENZIMIDAZOLE RIBOSIDE; ADENOSINE TRIPHOSPHATE; CASEIN KINASE II; GLYCEROL; LIGAND; PROTEIN KINASE INHIBITOR;

ARTICLE; BINDING COMPETITION; BINDING SITE; BIOLOGY; CALORIMETRY; CHEMICAL STRUCTURE; CHEMISTRY; DRUG ANTAGONISM; DRUG EFFECT; ENZYME ACTIVE SITE; HUMAN; KINETICS; METABOLISM;

ADENOSINE TRIPHOSPHATE; ALLOSTERIC SITE; BINDING, COMPETITIVE; CALORIMETRY; CASEIN KINASE II; CATALYTIC DOMAIN; COMPUTATIONAL BIOLOGY; DICHLORORIBOFURANOSYLBENZIMIDAZOLE; GLYCEROL; HUMANS; KINETICS; LIGANDS; MODELS, MOLECULAR; PROTEIN KINASE INHIBITORS;

EID: 39149130330     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chembiol.2007.12.012     Document Type: Article

References (22)

1. Boldyreff B., Meggio F., Pinna L.A., and Issinger O.-G. Reconstitution of normal and hyperactivated forms of casein kinase-2 by variably mutated β-subunits. Biochemistry 32 (1993) 12672-12677
2. CCP4 (Collaborative Computational Project, Number 4). The CCP4 suite: programs for protein crystallography. Acta Crystallogr. D Biol. Crystallogr. 50 (1994) 760-763
3. Cornish-Bowden A. A simple graphical method for determining the inhibition constants of mixed, uncompetitive and non-competitive inhibitors. Biochem. J. 137 (1974) 143-144
4. Esnouf R.M. An extensively modified version of MolScript that includes greatly enhanced coloring capabilities. J. Mol. Graph. Model. 15 (1997) 132-134
5. Guerra B., and Issinger O.-G. Protein kinase CK2 and its role in cellular proliferation, development and pathology. Electrophoresis 20 (1999) 391-408
6. Huse M., and Kuriyan J. The conformational plasticity of protein kinases. Cell 109 (2002) 275-282
7. Kleywegt G.J. Recognition of spatial motifs in protein structures. J. Mol. Biol. 285 (1999) 1887-1897
8. Knight Z.A., and Shokat K.M. Features of selective kinase inhibitors. Chem. Biol. 12 (2005) 621-637
9. Laudet B., Barrette C., Dulery V., Renaudet O., Dumy P., Metz A., Prudent R., Deshire A., Dideberg O., Filhol O., et al. Structure-based design of small peptide inhibitors of protein kinase CK2 subunit interaction. Biochem. J. 408 (2007) 363-373
10. Manning G., Whyte D.B., Martinez R., Hunter T., and Sudarsanam S. The protein kinase complement of the human genome. Science 298 (2002) 1912-1934
11. Meggio F., Shugar D., and Pinna L.A. Ribofuranosyl-benzimidazole derivatives as inhibitors of casein kinase-2 and casein kinase-1. Eur. J. Biochem. 187 (1990) 89-94
12. Merritt E.A., and Bacon D.J. Raster3D: photorealistic molecular graphics. Methods Enzymol. 277 (1997) 505-524
13. Nayal M., and Honig B. On the nature of cavities on protein surfaces: application to the identification of drug-binding sites. Proteins 63 (2006) 892-906
14. Nie Z., Perretta C., Erickson P., Margosiak S., Almassy R., Lu J., Averill A., Yager K.M., and Chu S. Structure-based design, synthesis, and study of pyrazolo[1,5-a][1,3,5]triazine derivatives as potent inhibitors of protein kinase CK2. Bioorg. Med. Chem. Lett. 17 (2007) 4191-4195
15. Niefind K., Guerra B., Ermakova I., and Issinger O.-G. Crystal structure of human protein kinase CK2: insights into basic properties of the CK2 holoenzyme. EMBO J. 20 (2001) 5320-5331
16. Niefind K., Yde C.W., Ermakova I., and Issinger O.-G. Evolved to be active: sulfate ions define substrate recognition sites of CK2α and emphasise its exceptional role within the CMGC family of eukaryotic protein kinases. J. Mol. Biol. 370 (2007) 427-438
17. Otwinowski Z., and Minor W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276 (1997) 307-326
18. Schomburg D., and Reichelt J. BRAGI: a comprehensive protein modeling program system. J. Mol. Graph. 6 (1988) 161-165
19. Seldin D.C., and Leder P. Casein kinase IIα transgene-induced murine lymphoma: relation to theileriosis in cattle. Science 267 (1995) 894-897
20. Traxler P., and Furet P. Strategies toward the design of novel and selective protein tyrosine kinase inhibitors. Pharmacol. Ther. 82 (1999) 195-206
21. Wells J.A., and McClendon C.L. Reaching for high-hanging fruit in drug discovery at protein-protein interfaces. Nature 450 (2007) 1001-1009
22. Yde C.W., Ermakova I., Issinger O.-G., and Niefind K. Inclining the purine base binding plane in protein kinase CK2 by exchanging the flanking side-chains generates a preference for ATP as a cosubstrate. J. Mol. Biol. 347 (2005) 399-414